Return On Asset ratio Analysis of MoonLake Immunotherapeutics - Deep Dive
WARN : Please note that some of the values may not be in base currency

Latest FY ROA
Period Ending - Dec-23

-0.0087


Very Poor ROA
Period Ending - Dec-22
-65.03

Very Poor ROA
Growth
99.99 %
Trailing Twelve Months ROA
Period Ending - Dec-23

-41.55


Very Poor ROA
Most recent Quarter ROA
Period Ending - Mar-24

-2.45


Very Poor ROA
ROA Analysis of MoonLake Immunotherapeutics
ROA Ratio of MoonLake Immunotherapeutics with value of -41.55 means poor return on Assets in trailing twelve months.
ROA Ratio of MoonLake Immunotherapeutics with value of -2.45 means poor return on Assets in latest Quarter ending on Mar-24.
ROA Ratio of MLTX rose handsomely by 99.99 % this year.
ROA of MoonLake Immunotherapeutics is negative because of negative Income in last Financial Year , last Quarter and also in last twelve Months.
Other ROA Related Info of MLTX that may interest you.
MoonLake Immunotherapeutics Overview
CodePricePrevious PricePrice ChangeSector
MLTX40.1741.41 2.99 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Return On Asset
The return on assets (ROA) is a commonly used profitability ratio that shows how effectively a company uses its assets to generate profit.   more ..
Return On Asset Formula
ROA Related Ratios
ReturnOnEquityAssetTurnoverRatio
Tsr Profitability Index
Poor Profitability Stock
FY - Historical Return On Asset of MoonLake Immunotherapeutics
PeriodDec-23Dec-22Dec-21Dec-20
ROA-0.0087-65.03-46.92-0.078
Change99.99 %-38.61 %-60139.51 %
FY Chart of Return On Asset of MoonLake Immunotherapeutics


Note : All Data Generated at the End of Trading Hours (EOD Data)